labetalol hydrochloride

Generic: labetalol hydrochloride

Labeler: zydus lifesciences limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name labetalol hydrochloride
Generic Name labetalol hydrochloride
Labeler zydus lifesciences limited
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

labetalol hydrochloride 200 mg/1

Manufacturer
Zydus Lifesciences Limited

Identifiers & Regulatory

Product NDC 70771-1164
Product ID 70771-1164_2be8d068-1830-4767-9e97-8d774d9a6001
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207743
Listing Expiration 2026-12-31
Marketing Start 2017-12-05

Pharmacologic Class

Classes
adrenergic beta-antagonists [moa] beta-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707711164
Hyphenated Format 70771-1164

Supplemental Identifiers

RxCUI
896758 896762 896766
UNII
1GEV3BAW9J

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name labetalol hydrochloride (source: ndc)
Generic Name labetalol hydrochloride (source: ndc)
Application Number ANDA207743 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED in 1 BOTTLE (70771-1164-1)
  • 30 TABLET, FILM COATED in 1 BOTTLE (70771-1164-3)
  • 500 TABLET, FILM COATED in 1 BOTTLE (70771-1164-5)
  • 90 TABLET, FILM COATED in 1 BOTTLE (70771-1164-9)
source: ndc

Packages (4)

Ingredients (1)

labetalol hydrochloride (200 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2be8d068-1830-4767-9e97-8d774d9a6001", "openfda": {"unii": ["1GEV3BAW9J"], "rxcui": ["896758", "896762", "896766"], "spl_set_id": ["a3c0cc1e-1c01-4009-afdc-d35a66546aec"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (70771-1164-1)", "package_ndc": "70771-1164-1", "marketing_start_date": "20171205"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (70771-1164-3)", "package_ndc": "70771-1164-3", "marketing_start_date": "20171205"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (70771-1164-5)", "package_ndc": "70771-1164-5", "marketing_start_date": "20171205"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (70771-1164-9)", "package_ndc": "70771-1164-9", "marketing_start_date": "20171205"}], "brand_name": "Labetalol Hydrochloride", "product_id": "70771-1164_2be8d068-1830-4767-9e97-8d774d9a6001", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Adrenergic beta-Antagonists [MoA]", "beta-Adrenergic Blocker [EPC]"], "product_ndc": "70771-1164", "generic_name": "Labetalol Hydrochloride", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Labetalol Hydrochloride", "active_ingredients": [{"name": "LABETALOL HYDROCHLORIDE", "strength": "200 mg/1"}], "application_number": "ANDA207743", "marketing_category": "ANDA", "marketing_start_date": "20171205", "listing_expiration_date": "20261231"}